16-20465699-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_001308172.2(ACSM2A):c.360G>A(p.Trp120*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00679 in 1,613,930 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0050 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0070 ( 48 hom. )
Consequence
ACSM2A
NM_001308172.2 stop_gained
NM_001308172.2 stop_gained
Scores
2
3
2
Clinical Significance
Conservation
PhyloP100: 4.89
Genes affected
ACSM2A (HGNC:32017): (acyl-CoA synthetase medium chain family member 2A) This gene encodes a mitochondrial acyl-coenzyme A synthetase that is specific for medium chain fatty acids. These enzymes catalyze fatty acid activation, the first step of fatty acid metabolism, through the transfer of acyl-CoA. These enzymes also participate in the glycine conjugation pathway in the detoxification of xenobiotics such as benzoate and ibuprofen. Expression levels of this gene in the kidney may be correlated with kidney function. This gene and its paralog ACSM2B (Gene ID: 348158), both present on chromosome 16, likely arose from a chromosomal duplication event. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant 16-20465699-G-A is Benign according to our data. Variant chr16-20465699-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2646283.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACSM2A | NM_001308172.2 | c.360G>A | p.Trp120* | stop_gained | 3/14 | ENST00000573854.6 | NP_001295101.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACSM2A | ENST00000573854.6 | c.360G>A | p.Trp120* | stop_gained | 3/14 | 1 | NM_001308172.2 | ENSP00000459451.1 |
Frequencies
GnomAD3 genomes AF: 0.00501 AC: 762AN: 152184Hom.: 5 Cov.: 32
GnomAD3 genomes
AF:
AC:
762
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00495 AC: 1243AN: 250948Hom.: 3 AF XY: 0.00470 AC XY: 637AN XY: 135630
GnomAD3 exomes
AF:
AC:
1243
AN:
250948
Hom.:
AF XY:
AC XY:
637
AN XY:
135630
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00698 AC: 10199AN: 1461628Hom.: 48 Cov.: 34 AF XY: 0.00669 AC XY: 4865AN XY: 727120
GnomAD4 exome
AF:
AC:
10199
AN:
1461628
Hom.:
Cov.:
34
AF XY:
AC XY:
4865
AN XY:
727120
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00500 AC: 762AN: 152302Hom.: 5 Cov.: 32 AF XY: 0.00477 AC XY: 355AN XY: 74476
GnomAD4 genome
AF:
AC:
762
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
355
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
34
ALSPAC
AF:
AC:
34
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
78
ExAC
AF:
AC:
617
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | ACSM2A: BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
Vest4
0.28, 0.29
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at